Page Title goes here

Pharmanumbers Article Archive

2011

2010-09: “DDEP Sales & Prescription Performance 2010, Hints of the Future" (Drug Development & Delivery - September 2011 Issue). An examination of key trends that defined 2010 and how these figures may impact business going forward. (in press)

2010-06: “Numbers That Define the Business of Drug Delivery - 2011 Edition” (Drug Development & Delivery - June 2011 Issue). This article offers a peek at the numbers that define the business of Drug Delivery, which can provide a foundation to better plans and outcomes in the real world of drug delivery development and commercialization.

2010-05: “Two Questions for Drug Delivery” (Drug Development & Delivery - May 2011 Issue). Josef Bossart, PhD, raises debate about Drug Delivery’s role as a set of formulation technologies, a complement to the pharmaceutical industry toolbox, or as a business sector that develops technologies and products that provide for better therapeutic outcomes.

2011-04: “Drug Delivery: Products That Pop” (Drug Development & Delivery -  April 2011 Issue). A brief look at drug delivery products that are special; in terms of therapeutic and commercial value.

2010

2010-11: “Decade in Review - Drug Delivery Transactions", (Drug Delivery Technology Magazine - November/December 2010 Issue). The fourth article in the series examining the performance of drug delivery technologies, products and companies in the past decade. The focus in this article is on transactions that have shaped the strategy and outlook for the drug delivery industry. Ten transactions are highlighted, ranging from the acquisition of Alza in 2001 to King's foray into the drug deterrent sector in the latter part of the decade.

2010-10: “Decade in Review - Drug Delivery Company Performance", (Drug Delivery Technology Magazine - October 2010 Issue). The third article in the series examining the performance of drug delivery technologies, products and companies in the past decade. The focus in this article is on the financial performance of drug delivery companies and what it means for the industry going forward. Includes numbers and analysis.

2010-09: "Decade in Review - Drug Delivery Product Sales", (Drug Delivery Technology Magazine - September 2010 Issue). The second article in the series examining the performance of drug delivery technologies, products and companies in the past decade. The focus in this article is on the sales performance of DDEP and implications for the future. Includes numbers and analysis.

2010-06: “Oral Drug Delivery: The Numbers Behind the Business", (ONdrugDELIVERY - June 2010 Issue). This article takes data from the Bionumbers DDEP2009 report and discusses their implications for the development of oral drug delivery products. Includes numbers and analysis.

2010-05: "Drug Delivery Products & Technologies, a Decade in Review: Approved Products 2000 to 2009", (Drug Delivery Technology Magazine - May 2010 Issue). Co-authored with Kurt Sedo and Tugrul Kararli. A qualitative and quantitative review of drug delivery products approved by the FDA in the last decade. Includes numbers and analysis.

2010-02: “Opening the Black Box", (PMPS, Pharmaceutical Manufacturing and Packaging Sourcer (UK) - February 2010 Issue). A peek inside the black box of drug delivery enabled/enhanced product (DDEP) development to understand the parameters that influence outcomes. Includes numbers and analysis.

2010-01: "Product Development, Expectations & the Real World", (Drug Delivery Technology Magazine - January 2010 Issue). A discussion of the importance of establishing realistic expectations with all of the stakeholders in the context of drug delivery enabled/enhanced products (DDEP). Includes numbers and analysis.

2009

2009-07: "Up, Down, Sideways - A Look at Drug Delivery Strategy", (Drug Delivery Technology - July 2009 Issue).

2009-02: "Drug Delivery Prospects for the Next Decade: An Informal Survey of Big Pharma", (Drug Delivery Technology - February 2009 Issue).

2008

2008-09: "Turning Insight into Action a Bionumbers Interview", (Drug Delivery Technology - September 2008 Issue).

2008-03: "Addressing the Analgesic Gap in Breakthrough Cancer Pain", (Drug Delivery Technology - March 2008 Issue).

2007

2007-01: "Benchmarking Drug Delivery - Follow the Money", (Drug Delivery Technology - January 2007 Issue).

2006

2006-07: "Estimating the Value of Time in Biopharmaceutical Development" (Drug Delivery Technology - July 2006 Issue).

2006-06: "Parameters of Value - Drug Delivery Companies", (Drug Delivery Technology - June 2006 Issue).

2006-03: "Benchmarking Drug Delivery - Updated Product Terms", (Drug Delivery Technology - March 2006 Issue).

2006-01: "Benchmarking Drug Delivery - Business Development Resources", (Drug Delivery Technology - January 2006Issue).

2005 and earlier

2005-10: "Practices of Successful Partnering Companies - A Drug Delivery Perspective", (Drug Delivery Technology - October 2005 Issue).

2005-06: "What Big Pharma Companies Wished Drug Delivery Companies Practiced", (Drug Delivery Technology - June 2005 Issue).

2005-04: "Benchmarking Drug Delivery - Comparing Profit-Share & Royalty", (Drug Delivery Technology - April 2005 Issue).

2005-03: "Benchmarking Drug Delivery - Defining the Potential of Drug Delivery", (Drug Delivery Technology - March 2005 Issue).

2005-02: "Benchmarking Drug Delivery - Defining Product Benefit and Value", (Drug Delivery Technology - February 2005 Issue).

2004-10: "Benchmarking Drug Delivery - Biotech & Drug Delivery Product Performance", (Drug Delivery Technology - October 2004 Issue).

2004-09: "Benchmarking Drug Delivery - Product Terms", (Drug Delivery Technology - September 2004 Issue).

2004-07: "Benchmarking Drug Delivery - Technology Royalty Rates", (Drug Delivery Technology - July 2004 Issue).

Main Content Heading (h3)

Paragraph Heading (h4)

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software